The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19

Kanuni Sultan Suleyman Training and Research Hospital

Status: Unknown

Conditions: COVID; Pneumonia, Viral

Treatments: Device: Bedside lung ultrasound

Study type: Interventional

Funder types: Other

Identifiers

NCT04399681

KSSEAH--

Details and patient eligibility

About

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Full description

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with an informed consent
• Admission to emergency department with symptoms or signs of COVID-19

Exclusion criteria

• Absence of informed consent
• Patients under age of 18
• Presence of acute coronary syndrome
• Presence of chronic lung disease
• Pregnancy
• Presence of trauma
• Patients with a diagnosis of malignancy

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Suspected COVID-19 Group

Other group

Description:

Patients who admitted to emergency department with suspicion of COVID 19 pneumonia will be evaluated with POCUS/ bedside lung ultrasound.

Treatment:

Device: Bedside lung ultrasound